At a glance
Elixinol is a Colorado-founded hemp-derived CBD brand established in the United States in 2014. It is part of Elixinol Wellness Limited, an Australian public company traded on the ASX under EXL. The U.S. catalog currently spans gummies, tinctures, capsules, liposomal liquids, topicals and pet products, including both THC-free formulas and hemp-derived Delta-9 products. It is a cannabinoid wellness brand, not a licensed dispensary chain.
Founder and hemp history
Regional Elixinol company histories identify hemp entrepreneur Paul Benhaim as the founder and trace his commercial hemp work to the early 1990s, including Hemp Foods Australia. Elixinol itself was established in Colorado in 2014. The founder's longer hemp career and the brand's launch are related but distinct dates, so the company should not be described as selling Elixinol CBD products since 1991.
Ownership and corporate structure
Elixinol belongs to Elixinol Wellness Limited, whose Melbourne corporate office handles governance and investor relations. The group also owns businesses including Hemp Foods Australia, Mt Elephant, The Healthy Chef, Australian Superfood Co and Field Day. Elixinol Americas is the Colorado-based operating unit for the U.S. brand; the parent company's other food and pet brands should not be mistaken for Elixinol CBD SKUs.
Current U.S. products
The live U.S. store groups products into gummies, topicals, liposomes, tinctures, capsules and pet formulas. It also separates hemp-derived Delta-9 products from THC-free options and merchandises products around sleep, relaxation, activity, comfort and general wellness. Those navigation labels are intended-use categories, not evidence that a product treats insomnia, pain, anxiety or another disease.
Hemp sourcing and testing
Elixinol says its U.S. products use USA-grown hemp and describes a process that includes milling, extraction, decarboxylation, internal quality testing, manufacturing and third-party laboratory verification. The site publishes certificates of analysis. Consumers should match a certificate to the product and lot in hand and review cannabinoid content and contaminant panels rather than relying only on a general “lab verified” badge.
Markets and channels
The parent company describes Elixinol as operating across the Americas with additional licensing relationships abroad, including a U.K. trademark and know-how agreement with British Cannabis. A market presence or license agreement does not mean identical formulations are sold everywhere. Cannabinoid limits, claims, ingredients and retail channels differ by jurisdiction, so the local label and website control.
Public-company record
Unlike many CBD brands, Elixinol has a public-company reporting trail. Elixinol Wellness's 2025 half-year report described Elixinol Americas as an e-commerce-only operation during that period and identified Natalie Butler as group CEO from June 19, 2025. The reporting also distinguishes the Americas business from the group's Australian food and nutrition operations, which were the main revenue driver.
Awards and notable achievements
Elixinol's defensible milestones are its 2014 U.S. establishment, survival through a volatile CBD market, international licensing and inclusion in a publicly reported wellness group. Fresh research did not locate a complete current award ledger tying named Elixinol products to competitions, categories, placements and years. Generic “trusted” or “leading” claims are therefore not converted into awards.
Safety and regulatory limits
CBD and hemp-derived Delta-9 can interact with medications, cause side effects and trigger drug tests. Product legality varies, and a hemp-derived label does not make a cannabinoid intoxicant risk-free. Consult a qualified clinician for medical questions, keep products away from children and pets, and follow the package. The FDA has not approved retail CBD supplements to diagnose or treat general health conditions.
Source and claim limits. Founding history comes from Elixinol's regional corporate histories; present ownership and operations come from Elixinol Wellness and its financial reporting; product formats, sourcing and testing come from the current U.S. site. Wellness labels and company quality statements are attributed rather than treated as clinical proof. Related products, articles, events, jobs, retailers and media populate this page's automatic relationship gallery.